Physician profile
Ellen Roberts
NPI 1114422789
$620.25
in general payments reported to CMS, 2019-2025
8 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.49 · 2021: $206 · 2022: $128 · 2023: $69.07 · 2024: $103 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $275.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $274.24 | 2020-2022 | |
| Kerecis Limited | $156.96 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Novus Surgical Consultants | $61.87 | 2025 | |
| Alafair Biosciences, INC. | $38.70 | 2022 | |
| Integra Lifesciences Corporation | $32.77 | 2024-2025 | Integra, Cytal, Integra Dermal Regeneration Template |
| Solventum Corporation | $23.76 | 2025 | Promogran Prisma, Activ.A.C., 3m Cavilon |
| Convatec INC. | $16.81 | 2021 | |
| Kairos Surgical INC | $15.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.